
Ben SteinBenStein
Partner, Mergers & Acquisitions
Benjamin Stein is a Boston-based Corporate partner at Paul Hastings. He advises privately held and publicly traded companies across the company life cycle, including formation and founder matters, venture capital and growth-stage financings, buy- and sell-side mergers and acquisitions, initial public offerings, SEC-registered offerings, SEC compliance and corporate governance.
In addition, Ben represents venture capital, private equity firms and large strategic institutions in connection with their investments in emerging growth and later-stage companies and M&A transactions.
Ben represents clients across several industries, with a focus on the life sciences, technology and sports industries.
University of San Diego, School of Law, J.D., 2011
University of New Hampshire, B.A., 2008
Ankyra Therapeutics, a biotechnology company, in general corporate matters, including in its expanded collaboration with Johnson & Johnson to advance the clinical development of a drug conjugate that is in Phase 1 clinical trials for solid tumors.
Care Access Research, a clinical research company, in general corporate and M&A matters.
- Rising Star
New England Legal Awards
- Americas Rising Star Dealmaker
M&A Atlas Awards